Skip to content

Health Canada recalls Peppermint TUMS over contamination concern

Some tablets were found to contain fragments of fibreglass and other material
untitled
Health Canada urges anyone to purchased the recalled product to dispose of it immediately.

GlaxoSmithKline Consumer Healthcare ULC is recalling one lot of TUMS Peppermint Regular Strength tablets after some tablets were found to contain fragments of fibreglass and other material, including paper and aluminum foil.

The product is sold in a package of three rolls containing 12 tablets each, and was distributed across Canada starting on October 25, 2022.

The affected lot number is 019700240 HA7H with an expiry date of Aug. 2027.

Anyone who purchased a package is asked to stop using it and speak to a health care professional if you have health concerns.

TUMS is an antacid indicated for adult use to relieve indigestion and heartburn caused by too much acid in the stomach.

If consumed, the fragments should pass through most people's digestive systems with no concern; however, elderly people and people who have narrow areas in their intestines because of disease or surgery may be at risk of injury.

Health Canada is monitoring the company's recall and will update the public if any new health risks are identified.

Customers can return the product to a pharmacy for proper disposal and contact GSK Consumer Healthcare (doing business as Haleon) by calling
1-888-788-8181, or by emailing [email protected], if you have questions about this recall.

Report any health product adverse events or complaints to Health Canada.